Continuing with our mission to promote success in biomedical entrepreneurship, the I-Trep program offers
individual one-to-one consulting with experts to assist in the preparation of proposals and the management of awarded SBIR/STTR Grants.
Request for this consultant service is available year-round. The request will be submitted to the I-Trep administrative office where it will be discussed by the Steering Committee. If selected, the I-Trep program will put you in contact
with an expert to help you with your topic of interest. The I-Trep program will cover the consultation fee (maximum amount $3500). While there is no deadline for the requests, awards will be funded on a first come first served basis.
*Complete the one-page application and email it to email@example.com*
Eva Garland Consulting was founded by Dr. Eva Garland, who excels in securing resources and leading scientific teams to develop innovative new technologies that span the biological and physical sciences. As Vice President of Research &
Development for an early stage biotechnology company, Dr. Garland was awarded over $12 million in grant funding, including twelve SBIR/STTR Awards as well as funding from Foundations and state and local sources. Dr. Garland and
her team have secured hundreds of additional grants totaling over $100 million for technologies ranging from pharmaceuticals, wound care products, antiseptics, medical devices, agrochemicals, and industrial products.
Yolanda Nesbeth Ph.D.
Dr. Nesbeth received her Ph.D. in Microbiology and Immunology from Dartmouth Medical School. During her graduate career, she developed therapeutic cell-based technologies and immunotherapies against ovarian cancer. Yolanda previously worked as
a Consultant with Clarion Healthcare providing strategic advice to pharmaceutical and biotechnology companies on key scientific and commercial matters related to drug development, promotion, and regulatory processes. Yolanda is currently
a Director at Celdara Medical where she leads multiple internal therapeutic development programs, in addition to managing a CLIA certified lab providing molecular diagnostics for systemic sclerosis patients, clinicians, and drug developers.
She serves as a Reviewer for DOD and NIH SBIR/STTR study sections and is a member of various biotech organizations.